Atlas Trials

The Effect of Metformin As an Adjuvant Therapy on Immunological Parameters in Egyptian Patients with RRMS: a Pilot Study

Clinical trial NCT06812585 · COMPLETED

Trial details

NCT number
NCT06812585
Sponsor
German University in Cairo
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Sclerosis (MS) - Relapsing-remitting
Start date
2022-04-01
Primary completion
2023-05-30
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.